Abstract:Funding Acknowledgements Type of funding sources: Public grant(s) – EU funding. Main funding source(s): Health Research Fund (Fondo de Investigación Sanitaria [FIS]) from the Instituto de Salud Carlos III Introduction Endothelial dysfunction (ED) is pivotal in Chronic Thromboembolic Pulmonary Hypertension (CTEPH) due to structural and functional alterations in endothelial. Previous studies have shown the critical function of cytoskeletal elements, particularly actin microfilaments and microtubules, along with associated cell adhesion complexes, in the endothelial integrity. Nevertheless, precise alterations in the cytoskeletal elements of endothelial cells (ECs) in CTEPH patients remain unclear. Purpose This study aims to investigate the cytoskeleton changes in CTEPH-ECs compared to healthy ECs, characterizing morphological and structural differences. Objectives involve assessing microtubules and microfilaments expression, and their influence on ECs migratory capacity. Finally, our study aims to gain novel insights into the spatial organization of cytoskeleton components in CTEPH patients. Methods CTEPH-ECs were isolated from freshly resected pulmonary endarterectomy specimens of CTEPH patients, while human pulmonary artery ECs (HPAE) were used as healthy controls. Fluorescence immunocytochemistry assessed phenotypic and compositional characteristics of the cytoskeleton. Morphometric analysis described morphology and filament organization of cytoskeletal proteins using a custom-built pipeline. X-ray microscopy examined the phenotype and cytoskeletal components distribution. The migration assay evaluated how these structural differences affected ECs migratory capacity and the cytoskeletal elements expression. Results CTEPH-ECs exhibited larger surface area (1352 vs 662μm2, p<0.01) and a more stellate morphology (0.365 vs 0.289, p<0.01) than HPAE-ECs. Immunostaining indicated altered cytoskeletal composition in CTEPH-ECs with significantly higher tubulin expression, expressed in microtubules, (3327 vs 2238AU, p<0.01) and F-actin microfilaments (2068 vs 1300AU, p<0.01) compared to HPAE. Similarly, CTEPH-ECs showed reduced G-actin expression (3002 vs 7461AU, p<0.01). Morphometric analysis demonstrated that microfilaments were thinner (0.623 vs 0.831AU, p<0.01), more straight (0.135 vs. 0.172, p<0.01) and more aligned (0.132 vs. 0.156, p<0.01) in CTEPH-ECs. Microtubule thickness decreased compared to HPAE-ECs (0.341 vs 1.371AU, p<0.01). CTEPH-ECs showed impaired wound healing (60 vs 89% closure, p<0.05). CTEPH group showed an increase in microtubules and microfilaments expression during wound healing, but with irregular patterns, unlike the constant levels in HPAE. TXM-technology revealed spatial organization differences, especially expansive microtubules distribution in CTEPH-ECs (4.2*10^7 vs. 8.7*10^6 nm3, p<0.05). Conclusion These preliminary findings highlight significant structural and compositional differences in CTEPH-ECs, along with altered wound healing capacity, suggesting dynamic cytoskeletal and cellular changes in CTEPH. Understanding these alterations is crucial for advancing CTEPH knowledge and identifying potential therapeutic targets.

Endothelial cells in chronic thromboembolic pulmonary hypertension exhibit cytoskeletal alteration

Comparative analysis of circulating endothelial progenitor cells and resected tissue-derived endothelial cells in chronic thromboembolic pulmonary hypertension (CTEPH).

Endothelial-like cells in chronic thromboembolic pulmonary hypertension: crosstalk with myofibroblast-like cells

The Distinguishing Cellular Features of Pulmonary Artery Smooth Muscle Cells from Chronic Thromboembolic Pulmonary Hypertension Patients.

Single-Cell Analysis Reveals Distinct Immune and Smooth Muscle Cell Populations that Contribute to Chronic Thromboembolic Pulmonary Hypertension

Shear stress-exposed pulmonary artery endothelial cells fail to upregulate HSP70 in chronic thromboembolic pulmonary hypertension

Endothelial features along the pulmonary vascular tree in chronic thromboembolic pulmonary hypertension: distinctive or shared facets?

Angiostatic factors in the pulmonary endarterectomy material from chronic thromboembolic pulmonary hypertension patients cause endothelial dysfunction

Identification of Putative Endothelial Progenitor Cells (Cd34+cd133+flk-1+) in Endarterectomized Tissue of Patients with Chronic Thromboembolic Pulmonary Hypertension.

Multipotent Mesenchymal Progenitor Cells Are Present in Endarterectomized Tissues from Patients with Chronic Thromboembolic Pulmonary Hypertension

Characterization of myofibroblasts in chronic thromboembolic pulmonary hypertension

Abstract 12433: Distinct Immune and Mesenchymal Populations Identified by Single Cell RNA Sequencing Contribute to Chronic Thromboembolic Pulmonary Hypertension

Exploring the Endothelin-1 pathway in chronic thromboembolic pulmonary hypertension microvasculopathy

The Inflammatory Profile of CTEPH-Derived Endothelial Cells Is a Possible Driver of Disease Progression

Endothelial Overexpression of TGF-β-Induced Protein Impairs Venous Thrombus Resolution: Possible Role in CTEPH

Study of a novel hypoxia system to evaluate endothelial cell dysfunction in chronic thromboembolic pulmonary hypertension (CTEPH)

Electrophysiological Characterization of Cells Isolated from Endarterectomized Tissue from Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH).

Low diffusing capacity for carbon monoxide in chronic thromboembolic pulmonary hypertension: a biomarker for microvascular disease?

ANALYSIS OF T CELL IMMUNE FUNCTION OF 16 PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION

Thrombosis is Not the Only Determinant of Chronic Thromboembolic Pulmonary Hypertension

Chronic thromboembolic pulmonary disease: Association with exercise-induced pulmonary hypertension and right ventricle adaptation over time